nach oben

Current Treatment Options in Gastroenterology

Erschienen in:

22.12.2023

Infective Esophagitis: a Review of Esophageal Diseases in HIV

verfasst von: Aleem Azal Ali, BSc MBBS, Kimberly Sanders, DO, Anna Marie McCarthy, MD MPH, Kintin Ng, DO, Ahmad Alkhasawneh, MD, Carmen Isache, MD, Ron Schey, MD FACG

Erschienen in: Current Treatment Options in Gastroenterology | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

Esophageal diseases are a common manifestation of HIV infection, and in some cases may be the first presentation of an underlying, severely immunocompromised state. The esophagus may be the site of the first acquired immunodeficiency syndrome (AIDS)–defining opportunistic illness in a large number of patients, and this review highlights varying clinical presentations and symptoms of esophageal diseases in HIV.

Recent Findings

Infective esophagitis often signals the onset of symptomatic HIV infection and endoscopic evaluation with biopsies is instrumental in their diagnosis and management. As esophageal diseases in HIV are present, there is notable advancement in the diagnostic approach and pharmacotherapeutics.

Summary

This review briefly highlights various esophageal diseases related to underlying HIV infection and outlines recent updates in diagnosis, management, and available treatment options.

López-Dupla M, Mora Sanz P, PintadoGarcía V, et al. Clinical, endoscopic, immunologic, and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV-infected patients: a survey of 114 cases. Am J Gastroenterol. 1992;87(12):1771–6.PubMed

Takahashi Y, Nagata N, Shimbo T, et al. Long-term trends in esophageal candidiasis prevalence and associated risk factors with or without HIV infection: lessons from an endoscopic study of 80,219 patients. PLoS One. 2015;10(7):e0133589. https://doi.org/10.1371/journal.pone.0133589. (Published 2015 Jul 24).CrossRefPubMedPubMedCentral

Pons V, Greenspan D, Lozada-Nur F, et al. Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions. Clin Infect Dis. 1997;24(6):1204–7. https://doi.org/10.1086/513664.CrossRefPubMed

Vazquez JA. Optimal management of oropharyngeal and esophageal candidiasis in patients living with HIV infection. HIV AIDS (Auckl). 2010;2:89–101. https://doi.org/10.2147/hiv.s6660.CrossRefPubMed

Benson CA, Kaplan JE, Masur H, et al. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America [published correction appears in MMWR Morb Mortal Wkly Rep. 2005 Apr 1;54(12):311]. MMWR Recomm Rep. 2004;53(RR-15):1–112

Laine L, Dretler RH, Conteas CN, et al. Fluconazole compared with ketoconazole for the treatment of Candida esophagitis in AIDS. A Randomized trial Ann Intern Med. 1992;117(8):655–60. https://doi.org/10.7326/0003-4819-117-8-655.CrossRefPubMed

Barbaro G, Barbarini G, Di Lorenzo G. Fluconazole vs. flucytosine in the treatment of esophageal candidiasis in AIDS patients: a double-blind, placebo-controlled study. Endoscopy. 1995;27(5):377–83. https://doi.org/10.1055/s-2007-1005717.CrossRefPubMed

Barbaro G, Barbarini G, Calderon W, Grisorio B, Alcini P, Di Lorenzo G. Fluconazole versus itraconazole for candida esophagitis in acquired immunodeficiency syndrome. Candida Esophagitis. Gastroenterology. 1996;111(5):1169–77. https://doi.org/10.1053/gast.1996.v111.pm8898629.CrossRefPubMed

Wilcox CM, Darouiche RO, Laine L, Moskovitz BL, Mallegol I, Wu J. A randomized, double-blind comparison of itraconazole oral solution and fluconazole tablets in the treatment of esophageal candidiasis. J Infect Dis. 1997;176(1):227–32. https://doi.org/10.1086/514028.CrossRefPubMed

10.

Villanueva A, Gotuzzo E, Arathoon EG, et al. A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis. Am J Med. 2002;113(4):294–9. https://doi.org/10.1016/s0002-9343(02)01191-9.CrossRefPubMed

11.

Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(5):503–35. https://doi.org/10.1086/596757.CrossRefPubMed

12.

Drew WL. Cytomegalovirus infection in patients with AIDS. Clin Infect Dis. 1992;14(2):608–15.CrossRefPubMed

13.

Weber JN, Thom S, Barrison I, Unwin R, Forster S, Jeffries DJ, et al. Cytomegalovirus colitis and esophageal ulceration in the context of AIDS: clinical manifestations and preliminary report of treatment with Foscarnet (phosphonoformate). Gut. 1987;28:482–7.CrossRefPubMedPubMedCentral

14.

• Yeh PJ, Wu RC, Chen CM, Chiu CT, Lai MW, Chen CC, Kuo CJ, Hsu JT, Su MY, Le PH. Risk factors, clinical and endoscopic features, and clinical outcomes in patients with cytomegalovirus esophagitis. J Clin Med. 2022;11(6):1583. https://doi.org/10.3390/jcm11061583.PMID:35329909;PMCID:PMC8955160. This is a recent study which highlights the risk factors of CMV esophagitis and the high mortality rate of patients with CMV esophagitis.CrossRefPubMedPubMedCentral

15.

Freedman PG, Weiner BC, Balthazar EJ. Cytomegalovirus esophagogastritis in a patient with acquired immunodeficiency syndrome. Am J Gastroenterol. 1985;80(6):434–7.PubMed

16.

Parente F, Cernuschi M, Valsecchi L, et al. Acute upper gastrointestinal bleeding in patients with AIDS: a relatively uncommon condition associated with reduced survival. Gut. 1991;32(9):987–90.CrossRefPubMedPubMedCentral

17.

Wilcox CM, Diehl DL, Cello JP, Margaretten W, Jacobson MA. Cytomegalovirus esophagitis in patients with AIDS. A clinical, endoscopic, and pathologic correlation. Ann Intern Med. 1990;113(8):589–93.CrossRefPubMed

18.

Dieterich DT, Wilcox CM. Diagnosis and treatment of esophageal diseases associated with HIV infection. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1996;91(11):2265–9.PubMed

19.

Wang HW, Kuo CJ, Lin WR, et al. Clinical characteristics and manifestation of herpes esophagitis: one single-center experience in Taiwan. Medicine (Baltimore). 2016;95(14): e3187. https://doi.org/10.1097/MD.0000000000003187.CrossRefPubMed

20.

Bonacini M, Young T, Laine L. The causes of esophageal symptoms in human immunodeficiency virus infection. A prospective study of 110 patients. Arch Intern Med. 1991;151(8):1567–72.CrossRefPubMed

21.

Zaidi SA, Cervia JS. Diagnosis and management of infectious esophagitis associated with human immunodeficiency virus infection. J Int Assoc Physicians AIDS Care (Chic). 2002;1(2):53–62. https://doi.org/10.1177/154510970200100204.CrossRefPubMed

22.

Wilcox CM, Straub RF, Schwartz DA. Prospective evaluation of biopsy number for the diagnosis of viral esophagitis in patients with HIV infection and esophageal ulcer. Gastrointest Endosc. 1996;44(5):587–93. https://doi.org/10.1016/s0016-5107(96)70014-7.CrossRefPubMed

23.

Jazeron JF, Barbe C, Frobert E, et al. Virological diagnosis of herpes simplex virus 1 esophagitis by quantitative real-time PCR assay. J Clin Microbiol. 2012;50(3):948–52. https://doi.org/10.1128/JCM.05748-11.CrossRefPubMedPubMedCentral

24.

Dekeyser S, El Nady M, Diaz E, Cassagnou M, Descamps D. Diagnostic d’oesophagite herpétique à HSV1 chez le sujet immunocompétent par PCR (Herpès Consensus Générique-Argène). A propos de six cas [Diagnosis of herpetic esophagitis in the immunocompetent subject by PCR (Herpès Consensus Générique-Argène). Report of six cases]. Pathol Biol (Paris). 2009;57(1):101–6. https://doi.org/10.1016/j.patbio.2008.07.005.CrossRefPubMed

25.

Rabeneck L, Popovic M, Gartner S, et al. Acute HIV infection presenting with painful swallowing and esophageal ulcers. JAMA. 1990;263(17):2318–22.CrossRefPubMed

26.

Wilcox CM, Schwartz DA. Comparison of two corticosteroid regimens for the treatment of HIV-associated idiopathic esophageal ulcer. Am J Gastroenterol. 1994;89(12):2163–7.PubMed

27.

Kayamba V, Bateman AC, Asombang AW, et al. HIV infection and domestic smoke exposure, but not human papillomavirus, are risk factors for esophageal squamous cell carcinoma in Zambia: a case-control study. Cancer Med. 2015;4(4):588–95. https://doi.org/10.1002/cam4.434.CrossRefPubMedPubMedCentral

28.

• Asombang AW, Chishinga N, Nkhoma A, et al. Systematic review and meta-analysis of esophageal cancer in Africa: epidemiology, risk factors, management and outcomes. World J Gastroenterol. 2019;25(31):4512–33. https://doi.org/10.3748/wjg.v25.i31.4512. This review discusses risk factors for esophageal cancer and highlights the role of HIV.CrossRefPubMedPubMedCentral

29.

Loots E, Sartorius B, Madiba TE, Mulder CJJ, Clarke DL. Oesophageal squamous cell cancer in a South African tertiary hospital: a risk factor and presentation analysis. S Afr J Surg. 2017;55(3):42–6.PubMed

30.

Horner MJ, Salima A, Chilima C, et al. Frequent HIV and young age among individuals with diverse cancers at a national teaching hospital in Malawi. J Glob Oncol. 2018;4:1–11. https://doi.org/10.1200/JGO.17.00174.CrossRefPubMed

31.

Thrift AP, Kramer JR, Hartman CM, et al. Risk and predictors of esophageal and stomach cancers in HIV-infected veterans: a matched cohort study. J Acquir Immune Defic Syndr. 2019;81(3):e65–72. https://doi.org/10.1097/QAI.0000000000002038.CrossRefPubMedPubMedCentral

32.

Kahl P, Buettner R, Friedrichs N, Merkelbach-Bruse S, Wenzel J, Heukamp LC, Kaposi’s sarcoma of the gastrointestinal tract: report of two cases and review of the literature. Pathol - Res Pract. 2007;203 4;227–231, vISSN 0344–0338, https://doi.org/10.1016/j.prp.2007.01.007

33.

Lee AJ et al. Gastrointestinal Kaposi’s sarcoma: case report and review of the literature. World J Gastrointest Pharmacol Ther. 2015;6,3:89–95. https://doi.org/10.4292/wjgpt.v6.i3.89.

34.

Carmo J, Marques SC, Bispo M, Pinto D, Chagas C. Clinical and endoscopic features of gastrointestinal kaposi sarcoma: a single-center Portuguese experience over the last decade. GE Port J Gastroenterol. 2017;24(5):219–26. https://doi.org/10.1159/000461592.CrossRefPubMedPubMedCentral

35.

Kalogeropoulos IV, Chalazonitis AN, Tsolaki S, Laspas F, Ptohis N, Neofytou I, Rontogianni D. A case of primary isolated non-Hodgkin’s lymphoma of the esophagus in an immunocompetent patient. World J Gastroenterol. 2009;15(15):1901–3. https://doi.org/10.3748/wjg.15.1901.CrossRefPubMedPubMedCentral

36.

Ghai S, Pattison J, Ghai S, O’Malley ME, Khalili K, Stephens M. Primary gastrointestinal lymphoma: spectrum of imaging findings with pathologic correlation. Radiographics. 2007;27(5):1371–88. https://doi.org/10.1148/rg.275065151.CrossRefPubMed

37.

Zalar AE, Olmos MA, Piskorz EL, Magnanini FL. Esophageal motility disorders in HIV patients. Dig Dis Sci. 2003;48(5):962–7. https://doi.org/10.1023/a:1023063916026.CrossRefPubMed

38.

Barrow PH, Mahomed A, Karlsson KA. HIV and achalasia. AIDS. 2005;19(15):1709–11. https://doi.org/10.1097/01.aids.0000186820.22865.ce.CrossRefPubMed

Titel: Infective Esophagitis: a Review of Esophageal Diseases in HIV
verfasst von: Aleem Azal Ali, BSc MBBS
Kimberly Sanders, DO
Anna Marie McCarthy, MD MPH
Kintin Ng, DO
Ahmad Alkhasawneh, MD
Carmen Isache, MD
Ron Schey, MD FACG
Publikationsdatum: 22.12.2023
Verlag: Springer US
Erschienen in: Current Treatment Options in Gastroenterology / Ausgabe 1/2024
Print ISSN: 1092-8472
Elektronische ISSN: 1534-309X
DOI: https://doi.org/10.1007/s11938-023-00435-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Infective Esophagitis: a Review of Esophageal Diseases in HIV